GL-V9, CAS [[1178583-19-1]]

Produktübersicht

• Artikelname: GL-V9, CAS [[1178583-19-1]]
• Artikelnummer: MCE-HY-126876
• Hersteller Artikelnummer: HY-126876
• Alternativnummer: MCE-HY-126876-5MG, MCE-HY-126876-10MG, MCE-HY-126876-100MG, MCE-HY-126876-50MG, MCE-HY-126876-25MG, MCE-HY-126876-1MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

GL-V9 inhibits proliferation of HepG2 cell (IC50 is 35.2 µM) through induction of apoptosis and cell cycle arrest at G2/M phase. GL-V9 regulates mitochondrial membrane potential and increases the production of intracellular reactive oxygen species. GL-V9 inhibits the pentose phosphate pathway (PPP), enhances fatty acid oxidation (FAO) through activation of AMPK, and thus inhibits the metastasis of cancer cells. GL-V9 exhibits antitumor efficacy in mouse model[1][2].

Produkteigenschaften

• Molekulargewicht: 409.47
• CAS Nummer: [1178583-19-1]
• Formel: C24H27NO5
• Target-Kategorie: AMPK,Apoptosis,Reactive Oxygen Species (ROS)

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound